文献速递头颈PETCT

头颈部鳞状细胞癌(化疗)放疗后首次PET-CT不完全缓解后的二次PET-CT

Second-look PET-CT following an initial incomplete PET-CT response to (chemo)radiotherapy for head and neck squamous cell carcinoma.
PubMed 文献 · Eur Radiol · 2019-08-29

本研究纳入2008至2017年间接受(化疗)放疗的头颈部鳞状细胞癌患者,评估首次疗效评估PET-CT不完全缓解后行二次PET-CT的效用。40例患者中60%二次PET-CT转为完全缓解,原发灶和淋巴结的阴性预测值分别为96%和100%,提示二次PET-CT可能避免不必要的手术干预。

要点

  • 首次PET-CT不完全缓解后,二次PET-CT显示60%(24/40)患者转为完全缓解。
  • 二次PET-CT对原发灶和淋巴结的阴性预测值分别高达96%和100%。
  • 二次PET-CT转为完全缓解后,原发灶和淋巴结均无进展病例。

核心结论

  • 多数接受二次PET-CT的患者转为完全缓解,其阴性预测值高,提示可能避免手术干预。

研究设计与样本

  • 回顾性纳入2008至2017年间接受(化疗)放疗的头颈部鳞状细胞癌患者562例,均行基线及疗效评估PET-CT,其中40例因首次疗效评估不完全缓解行二次PET-CT。

诊断标准与关键数值

  • 二次PET-CT对原发灶的敏感度75%、特异度75%、阳性预测值25%、阴性预测值96%;对淋巴结的敏感度100%、特异度92%、阳性预测值40%、阴性预测值100%。

临床应用与阅片要点

  • 当临床和影像学缓解存疑时,作者认为二次PET-CT可用于避免患者接受不必要的手术干预。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The limited positive predictive value of an incomplete response on PET-CT following (chemo)radiotherapy for head and neck squamous cell carcinoma (HNSCC) means that the optimal management strategy remains uncertain. The aim of the study is to assess the utility of a 'second-look' interval PET-CT.

METHODS: Patients with HNSCC who were treated with (chemo)radiotherapy between 2008 and 2017 and underwent (i) baseline and (ii) response assessment PET-CT and (iii) second-look PET-CT following incomplete (positive or equivocal scan) response were included. Endpoints were conversion rate to complete response (CR) and test characteristics of the second-look PET-CT.

RESULTS: Five hundred sixty-two patients with HNSCC underwent response assessment PET-CT at a median of 17 weeks post-radiotherapy. Following an incomplete response on PET-CT, 40 patients underwent a second-look PET-CT at a median of 13 weeks (range 6-25) from the first response PET-CT. Thirty-four out of 40 (85%) patients had oropharyngeal carcinoma. Twenty-four out of 40 (60%) second-look PET-CT scans converted to a complete locoregional response. The primary tumour conversion rate was 15/27 (56%) and the lymph node conversion rate was 14/19 (74%). The sensitivity, specificity, positive predictive value and negative predictive value (NPV) of the second-look PET-CT were 75%, 75%, 25% and 96% for the primary tumour and 100%, 92%, 40% and 100% for lymph nodes. There were no cases of progression following conversion to CR in the primary site or lymph nodes.

CONCLUSIONS: The majority of patients who undergo a second-look PET-CT convert to a CR. The NPV of a second-look PET-CT is high, suggesting the potential to avoid surgical intervention.

KEY POINTS: • PET-CT is a useful tool for response assessment following (chemo)radiotherapy for head and neck squamous cell carcinoma. • An incomplete response on PET-CT has a limited positive predictive value and optimal management is uncertain. • These data show that with a 'second-look' interval PET-CT, the majority of patients convert to a complete metabolic response. When there is doubt about clinical and radiological response, a 'second-look' PET-CT can be used to spare patients unnecessary surgical intervention.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Prestwich RJD, Arunsingh M, Zhong J, et al. Second-look PET-CT following an initial incomplete PET-CT response to (chemo)radiotherapy for head and neck squamous cell carcinoma. Eur Radiol. 2019. PMID: 31485835. doi:10.1007/s00330-019-06401-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。